Healthway Medical (5NG.SG) +2.6% at $0.195 in active trade, holding near 52-week high of $0.21 set last week, says Dow Jones.

Interest in past weeks driven by substantial shareholder Peter Lim increasing his stake to 7.21% via series of open market purchases. On fundamentals, DMG, which has Buy call with $0.30 target, says outlook for healthcare group favourable as it continues to make inroads in China using proceeds from placement of shares to World Bank’s International Finance Corp, other investors carried out earlier this year.

“(Healthway’s) specialist healthcare services are generally more expensive and profitable than primary healthcare services and there continues to be healthy demand for specialist services,” says DMG.

Shares not expected to challenge 52-week high for time being.